Study | Population (n) | Age (yr) | Success rate (%)a | Predictors of failure |
---|---|---|---|---|
Campion et al. [20] b,c prospective noncontrolled | Bronchiolitis (69) | 0.1 (0.03-1)d,e | 83 | Apnea Higher PaCO2 on admission Higher PRISM score at 24 hrs |
Bernet et al. [24] b prospective noncontrolled | Pneumonia (14), bronchiolitis (4), postoperative ARF (11), other (13) | 2.4 (0.01-18)d,e | 57 | FiO2 > 0.8 at 1 hr |
Joshi et al. [26] retrospective (primary parenchymal lung disease subgroup) | Pneumonia or ARDS (29) | 13d | 62 | Age ≤ 6 yr FiO2 > 0.6 within the first 24 hrs PaCO2 ≥ 55 mmHg within the first 24 hrs |
Essouri et al. [27] b retrospective | CAP (23), ARDS (9), ACS (9), immune deficiency (12), postextubation ARF (61) | 5.3 (0.04-16)e,f | 73 | ARDS High PELOD score |
Lum et al. [31] b prospective noncontrolled | Pulmonary diseases (129), postextubation ARF (149) | 0.7 (0.3-2.8)d,g | 76 | Higher FiO2 needs at start of NPPV Higher PRISM score on admission Sepsis at start of NPPV |
Munoz-Bonet et al. [54] prospective noncontrolled | Pneumonia (20), ARDS (10), postextubation ARF (11), other (6) | 7.1 (0.1-16)e,f | 81 | MAP > 11.5 cm H2O FiO2 > 0.6 |
Mayordomo-Colunga et al. [55] b prospective noncontrolled | Type I ARF (38), type II ARF (78) | 0.9 (0.05-14)d,e | 84 | Lower RR decrease at 1 hr and 6 hrs Higher PRISM score at start and at 1 hr Type I ARF |